The SomaScan Platform is being applied to a wide range of diseases and conditions to deliver insights that enable diagnostics development, pharmaceutical discovery, and health management.

The challenges encountered by proteomic researchers seeking diagnostic, prognostic and mechanistic markers were the subject of the 1-day meeting, Proteomics: Advances in Biomarker Discovery hosted ...

Hidden causes of diseases can be revealed by proteomics, which is instrumental in identifying new biomarkers and therapeutic targets to support drug discovery. In this webinar, you’ll hear from ...

This application note examines an advanced proteomics platform designed to provide high precision across thousands of ...

Understanding cellular heterogeneity is essential for deciphering the complexities of cellular subpopulations, ...

Scientists are revolutionizing microproteomics by combining droplet-based microfluidics with mass spectrometry. This approach ...

By employing cutting-edge technologies, such as AlphaFold3 and Python-based bioinformatics tools, Brenda bridges computational and experimental techniques to provide new insights into this poorly ...

Creative Proteomics today announced the launch of its advanced Mevalonate Pathway Analysis service.

Creative Proteomics has announced the launch of its state-of-the-art untargeted lipidomics platform.

Yeoun Jin Kim (Senior Director, AstraZeneca) discussed the challenges associated with implementing mass spec into clinical ...

Quantum-Si, protein sequencing technology provider, has collaborated with NVIDIA to develop its proteomics platform, Proteus, ...